COMMENT | Addressing mRNA vaccine safety and efficacy concerns
Modified1 Feb 2021, 11:58 pm
A
-
COMMENT | There have been a number of concerns highlighted about the messenger RNA (mRNA) vaccine over the last few weeks. As young Malaysian scientists, we would like to delve into the science or technology behind the mRNA vaccines in the hope that it would provide the people with a more wholesome understanding of the technology.
Like the general population, the scientific community was caught off guard by the sudden appearance of the Covid-19 virus. Among other initiatives, there was an urgent need for scientists to try to develop a vaccine that would stop the spread of the virus.
Wednesday, 23 Dec 2020 11:27 AM MYT
BY JERRY CHOONG
Health director-general Tan Sri Dr Noor Hisham Abdullah said all pharmaceutical products must be registered with the Drug Control Authority (DCA) following a quality, safety and efficacy evaluation process by the NPRA before they can be marketed in Malaysia. Picture by Miera Zulyana
Subscribe to our Telegram channel for the latest updates on news you need to know.
KUALA LUMPUR, Dec 23 It takes roughly three to four months to register a Covid-19 vaccine with the National Pharmaceutical Regulatory Agency (NPRA), said the Health Ministry.
Its director-general Tan Sri Dr Noor Hisham Abdullah said all pharmaceutical products must be registered with the Drug Control Authority (DCA) following a quality, safety and efficacy evaluation process by the NPRA before they can be marketed in Malaysia.